4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-20-002033
SVP & Chief Medical Officer sold 32,280 shares at an average $18.48 ($596,487)
- SVP & Chief Medical Officer acquired 32,280 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Paolini John F. · SVP & Chief Medical Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-19 | Exercise or conversion : show line 1 in the form | +22,477 | $3.80 | $85,413 | 40,477 | D |
| 2020-02-19 | Sale : show line 2 in the form | −22,477 | $18.27 | $410,655 | 18,000 | D |
| 2020-02-20 | Exercise or conversion : show line 3 in the form | +9,803 | $3.80 | $37,251 | 27,803 | D |
| 2020-02-20 | Sale : show line 4 in the form | −8,687 | $18.91 | $164,271 | 19,116 | D |
| 2020-02-20 | Sale : show line 5 in the form | −1,116 | $19.32 | $21,561 | 18,000 | D |
| Open-market sales · 32,280 sh · avg $18.48 · $596,487 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-19 | Exercise or conversion : show line 6 in the form Share Option | −22,477 | 76,345 | D |
| 2020-02-20 | Exercise or conversion : show line 7 in the form Share Option | −9,803 | 66,542 | D |
Loading xslF345X03/edgar.xml…